TuHURA Biosciences
HURA
8 hedge funds and large institutions have $164K invested in TuHURA Biosciences in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 0.09% → 0.07% (-0.02%)
10% less capital invested
Capital invested by funds: $181K → $164K (-$17.2K)
11% less funds holding
Funds holding: 9 → 8 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.67K |
| 2 |
JP Morgan Chase
New York
|
+$1.82K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$39.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6.71K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$107 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Geode Capital Management
Boston,
Massachusetts
| $56.6K | – | – | – |
|
2
State Street
Boston,
Massachusetts
| $43.2K | – | – | – |
|
3
Acadian Asset Management
Boston,
Massachusetts
| $25K | – | – | – |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $19.3K | +$9.67K | +85 | +167% |
|
5
Morgan Stanley
New York
| $13.5K | – | – | – |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $3.97K | – | – | – |
|
|
7
JP Morgan Chase
New York
| $2.25K | +$1.82K | +16 | New |
|
|
8
UBS Group
Zurich,
Switzerland
| $262 | -$6.71K | -59 | -97% |
|
9
Wells Fargo
San Francisco,
California
| $48 | – | – | – |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$39.2K | -305 | Closed |
|
|
11
Fidelity Investments
Boston,
Massachusetts
| – | -$107 | -1 | Closed |
|
HURA Hedge Fund Activity: Q2 2023 in Review
8 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q2 2023, worth a combined $164K — down 9.5% from $181K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of HURA and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $9.67K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $39.2K sold.
- 8 institutional investors held TuHURA Biosciences (HURA) as of Q2 2023, down from 9 in Q1 2023.
- Funds reported $164K of TuHURA Biosciences stock for Q2 2023, down 9.5% quarter-over-quarter.
- 1 fund opened new TuHURA Biosciences positions in Q2 2023 and 2 closed out, a net change of -1 holder.
- The largest TuHURA Biosciences buyer in Q2 2023 was Tower Research Capital (TRC), an estimated $9.67K added.
- The largest TuHURA Biosciences seller in Q2 2023 was Susquehanna International Group, an estimated $39.2K sold.
Based on aggregated 13F filings for Q2 2023.